Diseases [C] » Nutritional and Metabolic Diseases [C18] » Metabolic Diseases » Glucose Metabolism Disorders » Diabetes Mellitus » Diabetes Mellitus, Type 2
Diseases [C] » Endocrine System Diseases [C19] » Diabetes Mellitus » Diabetes Mellitus, Type 2
Description
A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. MeSH
Hierarchy View
Subtype Terms (1)
Diabetes Mellitus, Lipoatrophic
1 approved drug
Approved Indicated Drugs (40)
Phase 4 Indicated Drugs (194)
Phase 2 Indicated Drugs (253)
acetylcholine chloride (miochol)
allogeneic adipose derived mesenchymal stem cell
autologous bone marrow derived mesenchymal cells
autologous mesenchymal stem cells
Organization Involved with Phase 4 Indications (458)
Agency for Science, Technology and Research
Almazov National Medical Research Centre
Anhui College of Traditional Chinese Medicine
Aristotle University of Thessaloniki
Association of British Clinical Diabetologists
Atlanta Research and Education Foundation
Bangladesh Institute of Research and Rehabilitation in Diabetes
Canadian Institutes of Health Research (CIHR)
Canadian Medical and Surgical Knowledge Translation Research Group
Cardiology, University and Emergency Hospital, Bucharest, Romania
Carl T. Hayden Medical Research Foundation
Case Western Reserve University
Centre d’Etudes et de Recherche pour l’Intensification du Traitement du Diabète
Centre hospitalier de Mulhouse
Centre Hospitalier Universitaire de Nīmes
Centre Hospitalier Universitaire de Pointe-a-Pitre
Changzhou No.2 People's Hospital
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Clinical Practice Research Datalink
Clinical Research Centre, Malaysia
Clinical Research Institute HUCH Ltd
Consano Clinical Research, LLC
Council of Scientific and Industrial Research, India
Daewoong Pharmaceutical Co. LTD.
Diabeteszentrum Bad Lauterberg
Dnipropetrovsk State Medical Academy
East Tennessee State University
East West Medical Research Institute
Federal Ministry of Health, Germany
Federal University of Rio Grande do Sul
First People's Hospital, Shunde China
Fundação de Amparo à Pesquisa do Estado de São Paulo
Fundación Canaria Rafael Clavijo para la Investigación Biomédica
Fundacion Investigacion Interhospitalaria Cardiovascular
Fundación para la Investigación Biomédica del Hospital 12 de Octubre
General Hospital Dr. J. Bencevic
Guangdong Pharmaceutical University
Guangdong Provincial Hospital of Traditional Chinese Medicine
Gulf Regional Research & Educational Services, LLC
Hamilton Health Sciences Corporation
Handok Pharmaceuticals Co., Ltd.
Hannover Clinical Trial Center GmbH
Haugaard, Steen Bendix, M.D., DMSc
Haydarpasa Numune State Hospital
Helmholtz Centre for Infection Research
Hoosier Cancer Research Network
Hospital Universitario Central de Asturias
Hospital Virgen de la Victoria
Huai'an First People's Hospital
Huazhong University of Science and Technology
IInstituto Gallego de Medicina Vascular
India Diabetes Research Foundation
Instituto Nacional de Ciencias Medicas y Nutricion
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
International Diabetes Center, Minneapolis, MN 55416
Jothydev's Diabetes and Research Centre
Kansai Electric Power Hospital
King Edward Medical University
Kuhnil Pharmaceutical Co., Ltd.
Laboratorios Silanes S.A. de C.V.
Leadership Sinai Centre for Diabetes
LMC Diabetes & Endocrinology Ltd.
Medical Research Council, Sweden
Medical University of South Carolina
Menzies School of Health Research
Milton S. Hershey Medical Center
Mountain Diabetes and Endocrine Center
Nang Kuang Pharmaceutical Co., Ltd.
National Center for Research Resources (NCRR)
National Cerebral and Cardiovascular Center
National Cheng Kung University
National Heart, Lung, and Blood Institute (NHLBI)
National Institute for Health Research, United Kingdom
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institutes of Health (NIH)
National Nutrition and Food Technology Institute
National University of Singapore
Oregon Health and Science University
People's Liberation Army of China
Pierre and Marie Curie University
Postgraduate Institute of Medical Education and Research
Post-Graduate Medical Institute, Lahore
Principal SIMS/Services hospital lahore
Research Clinical Centre of the Russian Railways, JSC
Russian Federal Research Endocrinology center
Samuel Lunenfeld Research Institute
Second Military Medical University
Services Institute of Medical Sciences, Pakistan
Shaanxi Provincial People's Hospital
Shandong Province Qianfoshan Hospital
Singapore Clinical Research Institute
Skane County Council Research & Development Foundation
Spanish Biomedical Research Centre in Diabetes and Associated Metabolic Disorders
State University of New York, Buffalo
Steno Diabetes Center Copenhagen
St. Marianna University School of Medicine
Taichung Veterans General Hospital
Taipei Veteran General hospital
Tameside Hospital NHS Foundation Trust
Technical University of Munich
The Deutsche Diabetes Forschungsgesellschaft e.V.
The Royal Bournemouth Hospital
The Swedish National Diabetes Register
The University of Texas, Dallas
Thrombolysis In Myocardial Infarction Academic Research Organization
TSH Biopharm Corporation Limited
Universidad Autonoma de Barcelona
Universidad Autonoma de Ciudad Juarez
Universidad Complutense de Madrid
Université catholique de Louvain
University Hospital, Gentofte, Copenhagen
University of British Columbia
University of California, Riverside
University of Campania Luigi Vanvitelli
University of Naples Frederico II
University of Picardie Jules Verne
University of Roma La Sapienza
University of Rome Tor Vergata
University of Southern Denmark
University of Texas at Houston
University of Texas, Galveston
University of Texas, San Antonio
Virginia Commonwealth University
Vita-Salute University of Milano. Italy
Washington University in St. Louis
West Side Institute for Science and Education
Organization Involved with Phase 3 Indications (201)
All India Institute of Medical Sciences
Asociación para Evitar la Ceguera en México
Bethesda Diabetes Center, Hoogeveen
Bethesda General Hospital, Hoogeveen
Canadian Heart Research Centre
Centers for Disease Control and Prevention (CDC)
China Academy of Chinese Medical Sciences
Diabeteszentrum Bad Lauterberg im Harz
Dow University of Health Sciences
Federal University of Rio de Janeiro
Gan and Lee Pharmaceuticals, USA
Government Dental College and Research Institute, Bangalore
Hospital General de México Dr. Eduardo Liceaga
Hospital Universitario Arnau de Vilanova de Lleida
Icahn School of Medicine at Mount Sinai
Institut für Pharmakologie und Präventive Medizin
Iran University of Medical Sciences
Isala Clinics, Zwolle, The Netherlands
Islamic Azad University of Tabriz
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
Jiangsu Hansoh Pharmaceutical Co., Ltd.
King Faisal Specialist Hospital
National Health and Medical Research Council, Australia
National Institute on Aging (NIA)
National Medical Centre Siglo XXI Mexican Institute for Social Security
Northeast Ohio Medical University
North Jersey Endocrine Consultants
Ospedale Maggiore San Giovanni Bosco
Pharmaceutical Research Associates, Inc. (PRA)
Rajarata University, Sri Lanka
Reproductive Endocrinology Associates of Charlotte
Rio de Janeiro State University
Sanwa Kagaku Kenkyusho Co., Ltd.
Shanghai University of Traditional Chinese Medicine
Shijiazhuang Pharma Group (CSPC)
Sihuan Pharmaceutical Holdings Group Ltd.
Silesian University of Medicine
Swiss National Science Foundation
Technical University of Dresden
Tianjin University of Traditional Chinese Medicine
Top Institute Food and Nutrition
UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France
Unidad de Investigacion Medica en Enfermedades Renales
University of Colorado, Denver
University of Erlangen-Nuremberg
Organization Involved with Phase 2 Indications (266)
Achieve Clinical Research, LLC
Allegheny Singer Research Institute
Alliance Against Diabetes / AAD Clinical Research
American Institute of Research
Amrita Institute of Medical Sciences
Asociación Salvadoreña de Diabetes (ASADI)
Association for Innovation and Biomedical Research on Light and Image (AIBILI)
Association of International Professionals, dba Nevada Alliance Against Diabetes
Beijing Haijinge medicine Science-tech CO.
Bethune International Peace Hospital
Bharti Research Institute of Diabetes & Endocrinology
Castlerock Clinical Research Consultants, LLC
Centre Hospitalier Robert Bisson
Christian Medical College, Vellore, India
ConjuChem Biotechnologies Inc.
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Creekside Endocrine Associates
CTI Clinical Trial and Consulting Services
Dallas Diabetes and Endocrine Center
Deenanath Mangeshkar Hospital & Research Centre
Dr. V. Seshiah Diabetes Care & Research Institute
Dutch Diabetes Research Foundation
Eastern Virginia Medical School
Groupe Hospitalier Paris Saint Joseph
Innovent Biologics (Suzhou) Co. Ltd.
Institut National de la Santé Et de la Recherche Médicale, France
Instituto Mexicano del Seguro Social
Jacksonville Center for Clinical Research
John Muir Physician Network Clinical Research Center
Justus Liebig University Giessen
Juvenile Diabetes Research Foundation
Medwin Hospital, Hyderabad, AP, India
Mid-Atlantic Epilepsy and Sleep Center
Monks Park Primary care centre
M.S. Ramaiah Medical College, Bangalore, India
National Center for Complementary and Integrative Health (NCCIH)
National Clinical Research - Richmond, Inc.
National Research Institute - Wilshire
National University of Ireland
New Orleans Center for Clinical Research
Our Lady of Maryknoll Hospital
Pauls Stradins Clinical University Hospital
P.D. Hinduja Hospital and Medical Research Centre, Mumbai
Protenium Clinical Research, LLC
Radiological Society of North America
Rainier Clinical Research Center
Rajiv Gandhi University of Health Sciences
Satiogen Pharmaceuticals, Inc.
Secretaría Antidrogas de la Ciudad de San Salvador
Shahid Beheshti University of Medical Sciences
Shandong Xinhua Pharmaceutical Company
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Shoham Geriatric Medical Center, Pardes Hana, Israel
Singapore Bioimaging Consortium
Singapore Institute for Clinical Sciences
Tarakan Regional General Hospital
Texas Diabetes & Endocrinology, P.A.
The Canadian College of Naturopathic Medicine
The Hong Kong Polytechnic University
The Israeli Diabetes Research Group
The S. Daniel Abraham International Center for Health and Nutrition
Tishbi Wines, Israel and Admiral Wine Imports, US
Unidad Comunitaria de Salud Familiar Intermedia de Comasagua (UCSFI-Comasagua)
Universidad Dr. José Matías Delgado
University of Modena and Reggio Emilia
University of North Carolina at Chapel Hill
Wembley Health Care centre, NHS
Willamette Valley Cancer Institute
Organization Involved with Phase 1 Indications (77)
Beijing Chinese Medicine Hospital-Pinggu Hospital
Beijing Dongfang Biotech Co., Ltd.
CAR-T (Shanghai) Biotechnology Co.,Ltd.
Novum Pharmaceutical Research Services
Regenerative Medicine Minnesota
Sciwind Biosciences APAC CO Pty. Ltd.
Shanghai Xuhui District Central Hospital
Organization Involved with Other Experimental Indications (200)
Agriculture and Agri-Food Canada
Baqiyatallah Medical Sciences University
Beijing Sino-Japan Friendship Hospital
Bogomolets National Medical University
Canadian Cardiovascular Research Network
Canadian Collaborative Research Network
Casa Sollievo della Sofferenza IRCCS
Centro Especializado en Diabetes, Obesidad, Prevención y Enfermedades Cardiovasculares, S.C.
Commonwealth Scientific and Industrial Research Organisation, Australia
Cystic Fibrosis Foundation Therapeutics
District of Columbia Department of Health
Dutch Foundation for alcohol research
Fr Muller Homoeopathic Medical College
Garvan Institute of Medical Research
German Institute of Human Nutrition
Guangdong Science and Technology Bureau, China
Hellenic National Diabetes Center
Hochschule Geisenheim University
Indian Council of Medical Research
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Institute for Atherosclerosis Research, Russia
International Clinical Epidemiology Network (INCLEN) TRUST
International Clinical Trials Association
Japan Association for Diabetes Education and Care
Los Angeles Biomedical Research Institute
National Science Centre, Poland
National University of Malaysia
New York Obesity and Nutrition Research Center
Niigata University Medical & Dental Hospital
Norwegian Diabetes Association
Office of Dietary Supplements (ODS)
Omihachiman COmmunity Medical Center
Portsmouth Hospitals NHS Trust
Qingpu Central Hospital,Shanghai
Rashid Centre for Diabetes and Research
Rocky Mountain Diabetes and Osteoporosis Center, PA
Royal Veterinary and Agricultural University, Denmark
Second Okamoto General Hospital
Shanghai Qingpu Central Hospital
Sidra Medical and Research Center
Sitaram Bhartia Institute of Science and Research
St. Luke's-Roosevelt Hospital Center
Taras Shevchenko National University of Kyiv
The Danish Obesity Research Centre
The Physicians' Services Incorporated Foundation
Tsukiwa-machi, Seta, Otsu, Shiga, Japan
Universidad Autonoma del Estado de Mexico
University Clinical Centre of Kosova
University Hospital of North Norway
University of California, Davis
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Colorado, Colorado Springs
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.
